Results 241 to 250 of about 161,017 (342)

Synthesis and In Vitro Metabolic Profiling of the Selective Androgen Receptor Modulator (SARM) LY305

open access: yesRapid Communications in Mass Spectrometry, Volume 39, Issue 22, 30 November 2025.
ABSTRACT Rationale 2‐Chloro‐4‐[[(1R,2R)‐2‐hydroxy‐2‐methyl‐cyclopentyl]amino]‐3‐methyl‐benzonitrile (LY305) is a transdermal selective androgen receptor modulator (SARM) that has been under development as a potential therapeutic for conditions involving muscle wasting, osteoporosis, or hypogonadism.
Giorgi Kobidze   +4 more
wiley   +1 more source

Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo

open access: hybrid
Yue Huang   +11 more
openalex   +1 more source

In Vivo Biosynthesis and Direct Incorporation of Noncanonical Amino Acids into Proteins

open access: yesChemBioChem, Volume 26, Issue 22, November 17, 2025.
This review evaluates engineered (semi)autonomous cell systems for the biosynthesis and incorporation of noncanonical amino acids (ncAAs) into proteins. While semi‐autonomous cells convert supplied precursors into ncAAs autonomous cells integrate biosynthetic pathways that produce these building blocks intracellularly.
Jan Hendrik Illies   +2 more
wiley   +1 more source

Azaspiracid accumulation, detoxification and biotransformation in blue mussels (Mytilus edulis) experimentally fed Azadinium spinosum

open access: bronze, 2012
Thierry Jauffrais   +7 more
openalex   +2 more sources

Biotransformation of Sulfonamide Antibiotics in Activated Sludge: The Formation of Pterin-Conjugates Leads to Sustained Risk.

open access: yesEnvironmental Science and Technology, 2018
Stefan Achermann   +6 more
semanticscholar   +1 more source

Design and Characterization of Prodrugged Anti‐CTLA‐4 Antibodies

open access: yesChemBioChem, Volume 26, Issue 22, November 17, 2025.
Masking an anti‐CTLA‐4 antibody by conjugating a large PEG molecule to specific sites is explored as a way of mitigating undesirable activity in nontarget tissues. This prodrugged antibody exhibits reduced binding to CTLA‐4 and Fc gamma receptors, demonstrated high stability, and had an extended half‐life in a mouse model, potentially improving the ...
Sayumi Yamazoe   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy